| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f04b0008324a8d7dc7edf022bfe0bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ab0f295a7e78ca44473c16c595bea9 |
| publicationDate |
1997-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2168194-A1 |
| titleOfInvention |
Ifn-omega as anti hiv-agent |
| abstract |
The use of IFN-.omega. to combat HIV infection optionally in combination with a known anti-HIV agent is disclosed. Also disclosed are pharmaceutical compositions and kits comprising IFN-.omega. and at least one anti-HIV agent. |
| priorityDate |
1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |